Literature DB >> 6404227

Sodium valproate and neutropenia.

D N Symon, G Russell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404227      PMCID: PMC1627826          DOI: 10.1136/adc.58.3.235

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  Neutropenia during sodium valproate treatment.

Authors:  J Jaeken; C van Goethem; P Casaer; H Devlieger; E Eggermont; M Pilet
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

2.  Valproic acid and immune thrombocytopenia.

Authors:  R D Barr; S A Copeland; M L Stockwell; N Morris; J C Kelton
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

3.  Valproic acid therapy in childhood epilepsy.

Authors:  D L Coulter; H Wu; R J Allen
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

  3 in total
  4 in total

Review 1.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Neutropenia and Leukopenia After Cross Taper From Quetiapine to Divalproex for the Treatment of Borderline Personality Disorder.

Authors:  Caroline Richmond; Stephanie Coveart
Journal:  Fed Pract       Date:  2022-04-11

Review 3.  Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.

Authors:  Rosanne W Meijboom; Koen P Grootens
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

4.  Haematological disturbances during long-term valproate therapy.

Authors:  B Brichard; C Vermylen; J M Scheiff; J Ninane; G Cornu
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.